Key result
Single-cell studies in adrenocortical carcinoma reveal heterogeneous populations and unique immune system interplay.
Why the study?
Single-cell technologies have transformed the understanding of common cancers, but remain limited in scope for rare diseases such as adrenocortical carcinoma.
Single-cell studies reveal heterogeneous populations and unique immune interactions in adrenocortical carcinoma, suggesting potential mechanisms of therapeutic resistance.
Purpose of review Single-cell technologies have transformed our understanding of common cancers, though remain limited in scope for rare disease. The purpose of this review is to describe the impact of these studies on adrenocortical carcinoma. Recent findings Pangenomic studies in adrenocortical carcinoma have revealed that this disease is comprised of distinct molecular subtypes with prognostic import. Recent, though limited, single cell studies in adrenocortical carcinoma have characterized a unique interplay between steroidogenic cancer cell populations and the immune system. Summary Studies to date suggest that adrenocortical carcinoma is comprised of heterogeneous populations that coexist in specific ecotypes, with distinct features that may contribute to intrinsic therapeutic resistance. To leverage translational potential of these findings, large-scale multiinstitutional studies, including spatial information, are needed.
No takes yet. Share an insight, caveat, or question.
Mohan et al. (2026) conducted a review in Adrenocortical carcinoma. Single-cell technologies was evaluated. Single-cell studies in adrenocortical carcinoma reveal heterogeneous populations and a unique interplay between steroidogenic cancer cells and the immune system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: